Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

On 'The Adam Carolla Show' podcast, healthcare industry watchdog and wellness expert Calley Means shares why he believes the left used to question pharmaceutical companies, big institutions, and war ...

As Robert F. Kennedy Jr. settles into his role as President Donald Trump’s health secretary, one major promise he’s made is ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Soliman said consumers could see price increases or shortages of generic drugs in the country. There are some laws that ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.

Using detailed financial reports from thousands of firms, the researchers found that in 2018, U.S. multinationals shifted about $20-25 billion to tax havens — far lower than prior estimates of about ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...